Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Localised Prostate Carcinoma”

174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 174 results

Testing effectiveness (Phase 2)Looking for participantsNCT05806515
What this trial is testing

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8
SWOG Cancer Research Network 44
Large-scale testing (Phase 3)UnknownNCT00175396
What this trial is testing

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Who this might be right for
Prostate Cancer
University of British Columbia 400
Not applicableActive Not RecruitingNCT05027477
What this trial is testing

A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Profound Medical Inc. 201
Large-scale testing (Phase 3)WithdrawnNCT03488810
What this trial is testing

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Active Not RecruitingNCT02446444
What this trial is testing

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University of Sydney 802
Early research (Phase 1)WithdrawnNCT00691977
What this trial is testing

Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate

Who this might be right for
Prostate Cancer
Virginia Commonwealth University
Large-scale testing (Phase 3)Looking for participantsNCT06952803
What this trial is testing

Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Who this might be right for
Prostate Cancer
AstraZeneca 700
Early research (Phase 1)Looking for participantsNCT06613100
What this trial is testing

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 40
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Not applicableLooking for participantsNCT06270043
What this trial is testing

Focal Therapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Diego 500
Testing effectiveness (Phase 2)Study completedNCT02789878
What this trial is testing

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Instituto do Cancer do Estado de São Paulo 64
Testing effectiveness (Phase 2)Ended earlyNCT01704027
What this trial is testing

Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Centre Georges Francois Leclerc 28
Testing effectiveness (Phase 2)Looking for participantsNCT07455903
What this trial is testing

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Baptist Health South Florida 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03767244
What this trial is testing

Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 2,517
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Early research (Phase 1)Looking for participantsNCT07054346
What this trial is testing

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Who this might be right for
Prostate CancerProstate Cancer (Diagnosis)High-risk Prostate Cancer+2 more
Thomas Hope 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT07335796
What this trial is testing

BMS986365 in Combination With Degarelix in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 7
Large-scale testing (Phase 3)UnknownNCT00295802
What this trial is testing

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP TMS S.A. 141
Not applicableUnknownNCT04278261
What this trial is testing

Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer

Who this might be right for
Prostate CancerTreatment
Shanghai East Hospital 216
Not applicableStudy completedNCT03350529
What this trial is testing

MRI Guided Transurethral HIFU for Various Prostate Diseases

Who this might be right for
Localised Prostate CancerLocally Advanced Prostate CancerLocally Recurrent Prostate Cancer+1 more
Turku University Hospital 87
Next Page